SMARCA4 and ventricular septal defect: About 33% of SMC-Smarca4 knockout mice demonstrate cardiopulmonary abnormalities, including defects in the cardiac outflow tract, patent ductus arteriosus (PDA), and ventricular septal defect (VSD).